MEDISAN: The company's drugs, Rosuvastatin capsules and Chlorpromazine for injection, are expected to win the bidZhitong·Oct 29, 2025 at 02:52 AM002900-0.87%
The innovative drug concept strengthened at the beginning of the trading session, with MEDISAN and ALK both hitting the daily limitZhitong·Oct 21, 2025 at 08:41 PM002900-0.87%002940+3.97%
Zhitong A-share lock-up release overview | September 30Zhitong·Sep 29, 2025 at 08:01 PM001269+2.04%688661+18.74%
MEDISAN Pharmaceuticals: In the third phase of the 2022 incentive plan, 166 individuals can lift the sales restrictionsZhitong·Sep 17, 2025 at 05:27 AM002900-0.87%
MEDISAN released its performance for the first half of the year, turning from profit to a loss of 92.3904 million yuanZhitong·Aug 26, 2025 at 04:07 AM002900-0.87%
The A-share innovative drug concept continues to be strong, with YABAO PHARM.CORP hitting the limit up, and JENKEM, HSGC, YKYY, MEDISAN, HITECK, and others leading in gainsWallstreetcn·Jul 23, 2025 at 08:32 PM600351+0.94%688356+0.43%
MEDISAN: The injectable hydrochloride of Diltiazem has passed the consistency evaluation of generic drug quality and efficacyZhitong·Jul 23, 2025 at 02:58 AM002900-0.87%
The three major A-share indices collectively closed lower, with the pharmaceutical sector leading the gains36Kr·Jul 16, 2025 at 02:06 AM300010+3.29%300857+15.13%
Pharmaceutical stocks continued to rise in the afternoon, with LIVZON GROUP and nearly ten other stocks hitting the daily limitZhitong·Jul 16, 2025 at 01:11 AM002900-0.87%000513+0.39%
The innovative drug sector remains active, WBDE and MEDISAN saw their stocks locked in the afternoonZhitong·Jul 16, 2025 at 12:50 AM002900-0.87%000513+0.39%
Pharmaceutical stocks continue to be strong, FUSHILAI hits the 20% limit up, Tuoxin Pharmaceutical and Cosunter rise over 10%, Xizang Weixinkang Pharmaceutical, MEDISAN and several other stocks hit the limit upZhitong·Jul 7, 2025 at 08:48 PM301258+1.30%301089+2.04%
Three directors and executives of MEDISAN plan to reduce their holdings by a total of no more than 252,200 sharesZhitong·Jun 12, 2025 at 06:52 AM002900-0.87%
MEDISAN: Directors and senior executives Liang Yanfei, Zhu Zihong, and Zhao Zhicheng plan to reduce their shareholdingsZhitong·Jun 12, 2025 at 06:46 AM002900-0.87%
June 10th Midday Review: Shanghai Composite Index fluctuates narrowly, up 0.11%, innovative drug concept continues to be strongWallstreetcn·Jun 9, 2025 at 10:31 PM002940+3.97%002317+4.92%
The chemical pharmaceutical sector surged, with MEDISAN hitting the limit up, and HAINAN HAIYAO, EASTON BIOPHARMACEUTICALS, HWPC, CSPC Innovation, and ApicHope among the top gainersZhitong·May 29, 2025 at 08:33 PM688513+0.81%688799+3.19%
